Authors:
TAKASUNA K
HAGIWARA T
HIROHASHI M
KATO M
NOMURA M
NAGAI E
YOKOI T
KAMATAKI T
Citation: K. Takasuna et al., INHIBITION OF INTESTINAL MICROFLORA BETA-GLUCURONIDASE MODIFIES THE DISTRIBUTION OF THE ACTIVE METABOLITE OF THE ANTITUMOR AGENT, IRINOTECAN HYDROCHLORIDE (CPT-11) IN RATS, Cancer chemotherapy and pharmacology, 42(4), 1998, pp. 280-286
Authors:
MAKINO M
KITANO Y
KOMIYAMA C
HIROHASHI M
TAKASUNA K
Citation: M. Makino et al., INVOLVEMENT OF CENTRAL OPIOID SYSTEMS IN INTERFERON-INDUCED ENHANCEMENT OF IMMOBILITY IN THE FORGED SWIMMING TEST IN MICE, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 35171-35171
Citation: M. Makino et al., ENHANCEMENT OF IMMOBILITY IN MOUSE FORCED SWIMMING TEST BY TREATMENT WITH HUMAN INTERFERON, European journal of pharmacology, 356(1), 1998, pp. 1-7
Citation: Y. Lu et M. Hirohashi, ANALYSIS OF INTERFACIAL SHEAR-STRENGTH OF SIC AL COMPOSITE BY ACOUSTIC-EMISSION METHOD/, Scripta materialia, 38(2), 1997, pp. 273-278
Authors:
SHIBAMOTO Y
MIYAUCHI S
KIYOKAWA H
HIROHASHI M
TAKAHASHI M
Citation: Y. Shibamoto et al., ORAL VEHICLE ADMINISTRATION BEFORE RADIATION CAUSES RADIOPROTECTION OF MURINE SCCVII TUMORS, Oncology Reports, 4(4), 1997, pp. 787-789
Authors:
KITANO Y
USUI C
TAKASUNA K
HIROHASHI M
NOMURA M
Citation: Y. Kitano et al., INCREASING-CURRENT ELECTROSHOCK SEIZURE TEST - A NEW METHOD FOR ASSESSMENT OF ANTI-CONVULSANT AND PRO-CONVULSANT ACTIVITIES OF DRUGS IN MICE, Journal of pharmacological and toxicological methods, 35(1), 1996, pp. 25-29
Authors:
TAKASUNA K
HAGIWARA T
HIROHASHI M
KATO M
NOMURA M
NAGAI E
YOKOI T
KAMATAKI T
Citation: K. Takasuna et al., INVOLVEMENT OF BETA-GLUCURONIDASE IN INTESTINAL MICROFLORA IN THE INTESTINAL TOXICITY OF THE ANTITUMOR CAMPTOTHECIN DERIVATIVE IRINOTECAN HYDROCHLORIDE (CPT-11) IN RATS, Cancer research, 56(16), 1996, pp. 3752-3757
Authors:
MURATA R
SHIBAMOTO Y
MIYAUCHI S
HIROHASHI M
TAKAGI T
SASAI K
OYA N
HIRAOKA M
Citation: R. Murata et al., THE COMBINED ANTITUMOR EFFECT OF A NEW 5-FLUOROURACIL DERIVATIVE, BOF-A2, AND RADIATION IN-VIVO, British Journal of Cancer, 74, 1996, pp. 114-116
Authors:
SHIBAMOTO Y
MURATA R
MIYAUCHI S
HIROHASHI M
TAKAGI T
SASAI K
SHIBATA T
OYA N
TAKAHASHI M
Citation: Y. Shibamoto et al., COMBINED EFFECT OF CLINICALLY RELEVANT DOSES OF EMITEFUR A NEW 5-FLUOROURACIL DERIVATIVE, AND RADIATION IN MURINE TUMORS, British Journal of Cancer, 74(11), 1996, pp. 1709-1713
Citation: K. Hayashizaki et al., EFFECT OF EGG SIZE ON THE CHARACTERISTICS OF EMBRYOS AND ALEVINS OF CHUM SALMON, Fisheries science, 61(2), 1995, pp. 177-180
Authors:
TAKASUNA K
KASAI Y
KITANO Y
MORI K
KOBAYASHI R
HAGIWARA T
KAKIHATA K
HIROHASHI M
NOMURA M
NAGAI E
KAMATAKI T
Citation: K. Takasuna et al., PROTECTIVE EFFECTS OF KAMPO MEDICINES AND BAICALIN AGAINST INTESTINALTOXICITY OF A NEW ANTICANCER CAMPTOTHECIN DERIVATIVE, IRINOTECAN HYDROCHLORIDE (CPT-11), IN RATS, Japanese journal of cancer research, 86(10), 1995, pp. 978-984
Authors:
KITANO Y
MAKINO M
USUI C
TAKASUNA K
KASAI Y
HIROHASHI M
TAMURA K
TAKAYAMA S
KOJIMA H
IIZUKA H
YANAGITA T
Citation: Y. Kitano et al., GENERAL PHARMACOLOGICAL PROFILE OF THE NEW COGNITION-ENHANCING AGENT NEFIRACETAM, Arzneimittel-Forschung, 44-1(2A), 1994, pp. 199-210
Citation: K. Watanabe et al., EFFECT OF LITHIUM-OXIDE UPON HIGH-TC BISMUTH-SYSTEM SUPERCONDUCTOR (2223-PHASE), Materials research bulletin, 28(8), 1993, pp. 785-792
Authors:
HIROHASHI M
KIDO M
YAMAMOTO Y
KOJIMA Y
JITSUKAWA K
FUJII S
Citation: M. Hirohashi et al., SYNTHESIS OF 5-FLUOROURACIL DERIVATIVES CONTAINING AN INHIBITOR OF 5-FLUOROURACIL DEGRADATION, Chemical and Pharmaceutical Bulletin, 41(9), 1993, pp. 1498-1506
Authors:
HIROHASHI M
TAKASUNA K
KASAI Y
USUI C
TAMURA K
KOJIMA H
Citation: M. Hirohashi et al., GENERAL PHARMACOLOGICAL PROFILE OF THE NEW ANTIULCER DRUG YL)ETHYL]CARBAMOYL]METHYL]-AMINO-N-METHYLBENZAMIDE, Arzneimittel-Forschung, 43-1(5), 1993, pp. 569-577
Authors:
HIROHASHI M
TAKASUNA K
ASANO M
RYOKAWA Y
TAMURA K
Citation: M. Hirohashi et al., CARDIOVASCULAR PROPERTIES OF THE NEW ANTIULCER DRUG YL)ETHYL]CARBAMOYL]METHYL]-AMINO-N-METHYLBENZAMIDE, Arzneimittel-Forschung, 43-1(5), 1993, pp. 578-583